Literature DB >> 33717070

Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism.

Xiaohui Wei1, Song Wang1, Zhuolin Li1, Zibin Li1, Zehui Qu1, Suqiu Wang1, Baohua Zou1, Ruiying Liang1, Chun Xia1,2, Nianzhi Zhang1.   

Abstract

The micropolymorphism of major histocompatibility complex class I (MHC-I) can greatly alter the plasticity of peptide presentation, but elucidating the underlying mechanism remains a challenge. Here we investigated the impact of the micropolymorphism on peptide presentation of swine MHC-I (termed swine leukocyte antigen class I, SLA-I) molecules via immunopeptidomes that were determined by our newly developed random peptide library combined with the mass spectrometry (MS) de novo sequencing method (termed RPLD-MS) and the corresponding crystal structures. The immunopeptidomes of SLA-1*04:01, SLA-1*13:01, and their mutants showed that mutations of residues 156 and 99 could expand and narrow the ranges of peptides presented by SLA-I molecules, respectively. R156A mutation of SLA-1*04:01 altered the charge properties and enlarged the volume size of pocket D, which eliminated the harsh restriction to accommodate the third (P3) anchor residue of the peptide and expanded the peptide binding scope. Compared with 99Tyr of SLA-1*0401, 99Phe of SLA-1*13:01 could not form a conservative hydrogen bond with the backbone of the P3 residues, leading to fewer changes in the pocket properties but a significant decrease in quantitative of immunopeptidomes. This absent force could be compensated by the salt bridge formed by P1-E and 170Arg. These data illustrate two distinguishing manners that show how micropolymorphism alters the peptide-binding plasticity of SLA-I alleles, verifying the sensitivity and accuracy of the RPLD-MS method for determining the peptide binding characteristics of MHC-I in vitro and helping to more accurately predict and identify MHC-I restricted epitopes.
Copyright © 2021 Wei, Wang, Li, Li, Qu, Wang, Zou, Liang, Xia and Zhang.

Entities:  

Keywords:  RPLD–MS; crystal structure; immunopeptidome; micropolymorphism; swine MHC class I

Year:  2021        PMID: 33717070      PMCID: PMC7952875          DOI: 10.3389/fimmu.2021.592447

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  58 in total

1.  Polymorphism and peptide-binding specificities of porcine major histocompatibility complex (MHC) class I molecules.

Authors:  Shuhua Fan; Yongli Wang; Song Wang; Xian Wang; Yanan Wu; Zibin Li; Nianzhi Zhang; Chun Xia
Journal:  Mol Immunol       Date:  2017-07-24       Impact factor: 4.407

2.  Use of the 'Perceptron' algorithm to distinguish translational initiation sites in E. coli.

Authors:  G D Stormo; T D Schneider; L Gold; A Ehrenfeucht
Journal:  Nucleic Acids Res       Date:  1982-05-11       Impact factor: 16.971

3.  Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.

Authors:  Zehui Qu; Zibin Li; Lizhen Ma; Xiaohui Wei; Lijie Zhang; Ruiying Liang; Geng Meng; Nianzhi Zhang; Chun Xia
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

4.  Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.

Authors:  Shuhua Fan; Yanan Wu; Song Wang; Zhenbao Wang; Bo Jiang; Yanjie Liu; Ruiying Liang; Wenzhong Zhou; Nianzhi Zhang; Chun Xia
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

5.  Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.

Authors:  Jennifer G Abelin; Derin B Keskin; Siranush Sarkizova; Christina R Hartigan; Wandi Zhang; John Sidney; Jonathan Stevens; William Lane; Guang Lan Zhang; Thomas M Eisenhaure; Karl R Clauser; Nir Hacohen; Michael S Rooney; Steven A Carr; Catherine J Wu
Journal:  Immunity       Date:  2017-02-21       Impact factor: 31.745

6.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

7.  Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?

Authors:  Hanneke W M van Deutekom; Can Keşmir
Journal:  Immunogenetics       Date:  2015-06-04       Impact factor: 2.846

Review 8.  The MHC locus and genetic susceptibility to autoimmune and infectious diseases.

Authors:  Vasiliki Matzaraki; Vinod Kumar; Cisca Wijmenga; Alexandra Zhernakova
Journal:  Genome Biol       Date:  2017-04-27       Impact factor: 13.583

9.  A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.

Authors:  Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

10.  DeNovoGUI: an open source graphical user interface for de novo sequencing of tandem mass spectra.

Authors:  Thilo Muth; Lisa Weilnböck; Erdmann Rapp; Christian G Huber; Lennart Martens; Marc Vaudel; Harald Barsnes
Journal:  J Proteome Res       Date:  2014-01-07       Impact factor: 4.466

View more
  2 in total

1.  Peptidomes and Structures Illustrate How SLA-I Micropolymorphism Influences the Preference of Binding Peptide Length.

Authors:  Xiaohui Wei; Shen Li; Suqiu Wang; Guojiao Feng; Xiaoli Xie; Zhuolin Li; Nianzhi Zhang
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

Review 2.  New vistas unfold: Chicken MHC molecules reveal unexpected ways to present peptides to the immune system.

Authors:  Samer Halabi; Jim Kaufman
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.